Neogen Q3 revenue $218.3M (+70% YoY); adjusted EPS $0.12 vs $0.15 prior year

NEOGEN CORP

2023-Q3 EPS reported -$0.16 revenue$580,637,000

Revenue $218.3M (+70% YoY); core growth 4%, acquisition 68.1%, FX -1.9%.
Net income $8.2M ($0.04 diluted); Adjusted Net Income $26.5M ($0.12) vs $16.2M ($0.15) prior year.
Adjusted EBITDA $51.3M (23.5% margin) vs $24.9M (19.4%) prior year.
Food Safety segment revenue $151.5M (+141.5%); Animal Safety $66.7M (+1.9%).
Production backlog at 3M Food Safety transition partner; debt $900M, cash $183.2M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

NEOGEN CORP reported Fiscal 2023 third quarter and nine months ended February 28, 2023 results: revenue $218.3 million, net income $8.2 million, EPS $0.04 per diluted share.

Period: Fiscal 2023 third quarter and nine months ended February 28, 2023
Revenue: $218.3 million
Net income: $8.2 million
EPS: $0.04 per diluted share
Result: reported results

Exact text from the filing

report, regardless of any general incorporation language in the filing. --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 Neogen Announces Third-Quarter 2023 Results • Revenue of $218.3 million, an increase of 70% over the prior-year quarter. • Net income of $8.2 million; $0.04 per diluted share. • Adjusted Net Income of $26.5 million; $0.12 per diluted share. •

View on SEC.gov

Browse all earnings releases →

NEOGEN CORP filing history →

Source: SEC EDGAR

accession 0000950170-23-010746

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.